,
Daubin, Cédric http://orcid.org/0000-0002-3898-6296
Fournel, François
Thiollière, Fabrice
Daviaud, Fabrice
Ramakers, Michel
Polito, Andréa
Flocard, Bernard
Valette, Xavier
Du Cheyron, Damien
Terzi, Nicolas
Fartoukh, Muriel
Allouche, Stephane
Parienti, Jean-Jacques
Article History
Received: 26 October 2020
Accepted: 27 January 2021
First Online: 6 March 2021
Ethics approval and consent to participate
: This study was conducted according to the principles of the Declaration of Helsinki and pooled two data sets of prospective studies: BPCTrea (ClinicalTrials.gov, NCT02521636) and PROCALCIVIR studies. For BPCTrea, the study protocol was approved by the local research ethics committee (Comité de Protection des Personnes Nord Ouest III) for all participating centers. A written informed consent was obtained from the patients or their surrogates upon their enrollment in the study. For PROCALCIVIR, an ethical board decided that approval was not necessary given the observational nature of the study in accordance with French legislation about observational studies at the time of the study. According to French legislation about observational studies at the time of the study, no informed consent was obtained from the patients.
: Not applicable.
: The authors declare that they have no competing interests.